Abstract
Widespread changes to DNA methylation and chromatin are well documented in cancer, but the fate of higher-order chromosomal structure remains obscure. Here we integrated topological maps for colon tumors and normal colons with epigenetic, transcriptional, and imaging data to characterize alterations to chromatin loops, topologically associated domains, and large-scale compartments. We found that spatial partitioning of the open and closed genome compartments is profoundly compromised in tumors. This reorganization is accompanied by compartment-specific hypomethylation and chromatin changes. Additionally, we identify a compartment at the interface between the canonical A and B compartments that is reorganized in tumors. Remarkably, similar shifts were evident in non-malignant cells that have accumulated excess divisions. Our analyses suggest that these topological changes repress stemness and invasion programs while inducing anti-tumor immunity genes and may therefore restrain malignant progression. Our findings call into question the conventional view that tumor-associated epigenomic alterations are primarily oncogenic.
Original language | American English |
---|---|
Pages (from-to) | 1474-1489.e23 |
Journal | Cell |
Volume | 182 |
Issue number | 6 |
DOIs | |
State | Published - 17 Sep 2020 |
Bibliographical note
Funding Information:We thank Ryanne Boursiquot for assistance with sequencing; Mohammed Miri for assistance with clinical samples; Elizabeth Gaskell, Volker Hovestadt, Christine Eyler and Ryan Corcoran, Angela Shih, and Omer Yilmaz for thoughtful discussions; and Leslie Gaffney for graphic support. S.E.J. is supported by NIH T32CA009216 . A.R. and R.A.I. are supported by NIH R01GM083084 and R01HG005220 . J.H.C. is supported by NIH 1T32CA207021-01 . M.J.A. is supported by a Broad Institute Merkin Fellowship. B.E.B. is the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and an American Cancer Society Research Professor. This research was supported by the National Cancer Institute ( DP1CA216873 ) and the Starr Cancer Consortium . This paper is dedicated to the memory of Yaw Adu Kuffour.
Funding Information:
We thank Ryanne Boursiquot for assistance with sequencing; Mohammed Miri for assistance with clinical samples; Elizabeth Gaskell, Volker Hovestadt, Christine Eyler and Ryan Corcoran, Angela Shih, and Omer Yilmaz for thoughtful discussions; and Leslie Gaffney for graphic support. S.E.J. is supported by NIH T32CA009216. A.R. and R.A.I. are supported by NIH R01GM083084 and R01HG005220. J.H.C. is supported by NIH 1T32CA207021-01. M.J.A. is supported by a Broad Institute Merkin Fellowship. B.E.B. is the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and an American Cancer Society Research Professor. This research was supported by the National Cancer Institute (DP1CA216873) and the Starr Cancer Consortium. This paper is dedicated to the memory of Yaw Adu Kuffour. Conception and Experimental Design, S.E.J. A.R. M.J.A. and B.E.B.; Methodology and Data Acquisition, S.E.J. A.R. C.A. E.H. K.P. J.H.C. and B.E.B.; Analysis and Interpretation of Data, S.E.J. A.R. Y.Q. C.A. L.S.Z. Y.D. V.H. N.S. M.K.S. C.L. S.I. S.C.N. E.F.J. N.H. R.A.I. B.Z. M.J.A. and B.E.B. Manuscript Writing and Revision, S.E.J. A.R. M.J.A. and B.E.B. N.H. is an equity holder of BioNTech and a consultant for Related Sciences. M.J.A. declares outside interest in Excelsior Genomics. B.E.B. declares outside interests in Fulcrum Therapeutics, 1CellBio, HiFiBio, Arsenal Biosciences, Cell Signaling Technologies, BioMillenia, and Nohla Therapeutics.
Publisher Copyright:
© 2020 Elsevier Inc.
Keywords
- DNA methylation
- chromatin
- colon cancer
- compartment
- epigenetics
- genome topology
- nuclear architecture